Nanopath, a point-of-care diagnostics company, has received $4 million in federal grants from the National Institutes of Health (NIH) and the National Science Foundation (NSF). This funding is intended to support the development of Nanopath’s diagnostic platform, which focuses on pelvic and gynecologic infections and diseases. The grants were awarded through the competitive Small Business Innovation Research (SBIR) Program. The total federal…
Women’s health medtech company ASPIVIX has recenlty joined forces with Bayer Switzerland to introduce Carevix, a cervical stabilizer designed to minimize pain and bleeding during transcervical procedures, including IUD placement. This collaboration combines Bayer’s extensive expertise in contraceptive solutions with ASPIVIX’s dedication to modernizing gynecology. Their shared objective is to improve the gynecological experience for women, particularly by addressing the discomfort often…
In her book, “Invisible Women,” Carolina Criado Perez eloquently points out the pervasive gender biases that shape our public spaces: “When planners fail to account for gender, public spaces become male spaces by default.” This observation lays the groundwork for a broader discussion about the systematic marginalization and censorship faced by women and subsequently women’s health initiatives in both physical and digital…
Matrix Health and Care has been granted a patent from the USPTO for Matrix, an innovative self-use pelvic assessment tool aimed at enhancing gynecological examinations. Distinct from traditional speculums, Matrix emphasizes patient comfort and control, allowing for self-administration in clinical settings and integrating real-time data transmission for clinical evaluation and research. The patent marks a significant milestone for Matrix Health & Care…
Vivoo, a wellness app renowned for offering personalized nutrition and lifestyle guidance through at-home urine tests, has introduced a new at-home Urinary Tract Infection (UTI) testing product at CES 2024. This recent addition, recognized as a CES 2024 Innovation Awards honoree, delivers results within minutes and is aimed at simplifying the process of health monitoring and facilitating quicker connections with healthcare professionals.…
Aspivix, a company specializing in women’s health technology, has recently received CE Mark approval for its Carevix device, indicating its compliance with European health, safety, and environmental protection standards. This approval allows for the commercial use of Carevix in European countries. Carevix is designed to reduce pain during transcervical procedures, such as the placement of Intrauterine Devices (IUDs). It operates using a…
MiMARK Diagnostics, a company specializing in women’s health, has completed its first seed funding round, raising €4.22M. The funds are intended to advance their work in gynecological diagnostics, focusing on the use of gynecological fluids as a non-invasive source for biomarker detection. The company received €1.5M from EIT Health back in 2021. MiMARK is developing in vitro diagnostic solutions for managing gynecological…
Gynesonics, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, is pleased to announce that it has secured an incremental $42.5 million in financing (total of $67.2M inclusive of initial April 2023 financing). The round was led by existing Gynesonics investors Amzak Health, Endeavour Vision, Kaiser Permanente Ventures, Runway Growth Capital, and Bain Capital; with new…
